Among the studies mentioned previously, Hou et al. reported the synergistic effects of vorinostat with MAPK, mTOR, and AKT inhibitors to upregulate thyroid-specific gene expression and RAI accumulation in thyroid cancers (Table 2) 16. The gene discussed is MTOR; the disease is thyroid cancer.